A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Public ClinicalTrials.gov record NCT01179217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE III, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY OF L GLUTAMINE THERAPY FOR SICKLE CELL ANEMIA AND SICKLE ß0-THALASSEMIA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research is to evaluate the effects of L-glutamine as a therapy for Sickle Cell Anemia or Sickle ß0 Thalassemia as evaluated by the number of occurrences of sickle cell crises.
Study identification
- NCT ID
- NCT01179217
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 230 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 5 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Aug 19, 2020
2010 – 2014
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama Medical Center | Mobile | Alabama | 36617 | — |
| Phoenix Children's Hospital Center for Cancer and Blood Disorders | Phoenix | Arizona | 85016 | — |
| Kaiser Permanente | Inglewood | California | 90301 | — |
| Children's Hospital & Research Center at Oakland | Oakland | California | 94609 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90509 | — |
| University of Denver School of Medicine Sickle Cell Treatment & Research Center | Aurora | Colorado | 80045 | — |
| Howard University Hospital & Howard University | Washington D.C. | District of Columbia | 20060 | — |
| University of Florida | Gainesville | Florida | 32610-0296 | — |
| All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| Children's Healthcare of Atlanta at Egleston/Emory University | Atlanta | Georgia | 30322 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| University of Louisville School of Medicine | Louisville | Kentucky | 40202 | — |
| Sickle Cell Center of S. Louisiana, Tulane University School of Medicine | New Orleans | Louisiana | 70112 | — |
| Johns Hopkins University | Baltimore | Maryland | 21205 | — |
| Boston University Medical Center | Boston | Massachusetts | 02118 | — |
| Children's Hospital of Michigan | Detroit | Michigan | 48201 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Children's Mercy Hospitals and Clinics | Kansas City | Missouri | 64108 | — |
| Children's Specialty Center of Nevada | Las Vegas | Nevada | 89109 | — |
| Comprehensive Cancer Center of Nevada | Las Vegas | Nevada | 89109 | — |
| Cooper University Hospital | Camden | New Jersey | 08103 | — |
| The Brooklyn Hospital Center | Brooklyn | New York | 11201 | — |
| SUNY - Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Brookdale University Hospital and Medical Center | Brooklyn | New York | 11212 | — |
| New York Methodist Hospital - SC/Thalassemia Program | Brooklyn | New York | 11215 | — |
| Interfaith Medical Center | Brooklyn | New York | 11238 | — |
| Bronx Lebanon Hospital | The Bronx | New York | 11203 | — |
| Presbyterian Blume Pediatric Hematology-Oncology Clinic | Charlotte | North Carolina | 28204 | — |
| University of Tennessee Cancer Institute | Memphis | Tennessee | 38104 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298-0306 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01179217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01179217 live on ClinicalTrials.gov.